Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Oncopeptides

1.46 SEK

+6.33 %

Less than 1K followers

ONCO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Oncopeptides

EV/S

Median 2021-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)80.43107.565.327.704.861.384.53
Shares81.598.4118.8142.6142.7237.5274.0
Market cap6,559.310,583.3632.51,098.0692.8328.71,242.4
Enterprise value5,633.29,743.1270.3753.5625.8272.1-
EV/S--2.390.117.88.6-
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B8.2318.353.003.7312.206.06-21.10
P/S--5.3131.319.710.417.5
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio80.2 %60.9 %48.0 %76.4 %23.8 %22.2 %-43.7 %
Gearing ratio----187.5 %224.5 %-215.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.